Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1,566 JPY | -0.25% | -2.97% | +0.32% |
2023 | Delta-Fly Pharma, Inc. announced that it has received ¥503.7238 million in funding from Nippon Chemiphar Co., Ltd. | CI |
2023 | Global EV battery supply chain puzzles over China graphite curbs | RE |
ETFs positioned on Nippon Chemiphar Co., Ltd.
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.01% | 19 M€ | +11.32% | ||
0.00% | 17 M€ | +11.76% | - | |
0.00% | 63,295 M€ | +17.36% | - | |
0.00% | 140,441 M€ | +17.30% | ||
0.00% | 20,360 M€ | +16.11% | - |
1st Jan change | Capi. | |
---|---|---|
+0.32% | 36.79M | |
+32.09% | 693B | |
+29.39% | 584B | |
-1.34% | 372B | |
+20.34% | 332B | |
+7.39% | 294B | |
+14.25% | 239B | |
-3.03% | 211B | |
+10.02% | 210B | |
+8.49% | 168B |
- Stock Market
- Equities
- 4539 Stock
- Funds and ETFs Nippon Chemiphar Co., Ltd.